Clinical Trial Update: Detection of Pulmonary Embolism With CECT [Phase 4]

View source ↗

Summary

Phase 4 trial assessing detection of pulmonary embolism using contrast-enhanced CT has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• iodinated contrast agent (CECT imaging) (iodinated contrast agent)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Pulmonary Embolism | Phase 4 | Status: COMPLETED